ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $111 | -40.6% | 535 | 0.0% | 0.00% | – |
| Q1 2023 | $187 | +50.8% | 535 | -7.3% | 0.00% | – |
| Q4 2022 | $124 | – | 577 | -43.6% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1,023 | +91.2% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 535 | -0.6% | 0.00% | – |
| Q4 2021 | $1,000 | -99.4% | 538 | -98.7% | 0.00% | – |
| Q3 2021 | $173,000 | +17200.0% | 40,228 | +7419.3% | 0.00% | – |
| Q2 2021 | $1,000 | -92.3% | 535 | -89.7% | 0.00% | – |
| Q1 2021 | $13,000 | +1200.0% | 5,200 | +872.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 535 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 535 | -1.8% | 0.00% | – |
| Q4 2018 | $3,000 | +200.0% | 545 | +1.9% | 0.00% | – |
| Q3 2018 | $1,000 | – | 535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 293,908 | $494,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 315 | $1,000 | 0.00% |
| UBS Group AG | 1,692 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 650 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,985 | $131,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,900 | $3,000 | 0.00% |
| MORGAN STANLEY | 535 | $1,000 | 0.00% |
| BROWN ADVISORY INC | 26,040 | $44,000 | 0.00% |
| BlackRock Inc. | 205,684 | $346,000 | 0.00% |